1. Stocks
  2. Astria Therapeutics Inc
  3. Swot
swot-logo

Astria Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Astria Therapeutics Inc has 15 Strengths, 7 Weaknesses, 0 Opportunities and 4 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Companies with Low Debt

Stock gained more than 20% in one month

Book Value per share Improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

High Volume, High Gain

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Declining profits every quarter for the past 4 quarters

Stocks rising sharply on very low month volumes

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks